US Broker Ratings

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring an 84% Potential Upside in the Healthcare Sector

Alpha Teknova, Inc. (NASDAQ: TKNO) is capturing investor attention with its substantial potential upside. With a market cap of $319.04 million, this California-based healthcare company operates within the specialty and..

Pacific Biosciences of California (PACB) Stock Analysis: Investors Eye 81% Potential Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors seeking exposure to the burgeoning field..

Spok Holdings, Inc. (SPOK) Stock Analysis: A Healthcare Communication Leader with a 20% Upside

Investors looking for opportunities in the healthcare sector may want to keep an eye on Spok Holdings, Inc. (NASDAQ: SPOK), a company that specializes in health information services. With a..

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: Exploring a Promising 247% Upside Potential

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is capturing investor attention with an intriguing confluence of clinical potential and financial metrics. As a clinical-stage biotechnology firm, Cartesian Therapeutics is pioneering the development..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: A Promising Biotech with Over 500% Potential Upside

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) stands out in the biotechnology sector with a focus on developing innovative therapies for women’s cancers. Despite its current modest market cap of $279.16 million..

Aura Biosciences, Inc. (AURA) Stock Analysis: A 224% Potential Upside in the Biotech Sector

Aura Biosciences, Inc. (AURA), a clinical-stage biotechnology company, is capturing attention with a striking potential upside of 224.28%. This figure, derived from the average target price of $21.50 against its..

Quhuo Limited (QH) Investor Outlook: Navigating Challenges with a 52-Week High Potential

Quhuo Limited (QH), a notable player in the gig economy space in China, presents a complex yet intriguing profile for investors keen on the technology sector. With its headquarters in..

Nerdy Inc. (NRDY) Stock Analysis: Navigating Challenges and Opportunities in the Online Learning Sector

Nerdy Inc. (NRDY), a prominent player in the online learning industry, is navigating a complex financial landscape. With a market capitalization of $331.5 million, the company operates in the technology..

Candel Therapeutics, Inc. (CADL): Biotechnology Innovator with a 296.83% Potential Upside

Candel Therapeutics, Inc. (NASDAQ: CADL) is capturing attention in the biotechnology sector with its ambitious clinical programs and promising potential upside. With a market capitalization of $273.56 million, this United..

Sanara MedTech Inc. (SMTI) Stock Analysis: Exploring a 69.32% Potential Upside in Healthcare Innovation

Sanara MedTech Inc. (NASDAQ: SMTI) is carving out a niche within the healthcare sector, specifically in the medical instruments and supplies industry. Based in Fort Worth, Texas, this innovative company..

Immutep Limited (IMMP): Biotech Pioneer with a 413% Potential Upside

Immutep Limited (NASDAQ: IMMP), an Australian biotechnology firm, is making waves in the healthcare sector with its promising pipeline of LAG-3 related immunotherapies. As a late-stage biotech company, Immutep is..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring a 203% Potential Upside in the Biotech Sector

Heron Therapeutics, Inc. (NASDAQ: HRTX) is capturing investor attention with its substantial 203.40% potential upside, according to analyst ratings. As a player in the biotechnology sector, Heron Therapeutics focuses on..

Alpha Tau Medical Ltd. (DRTS): Analyst Consensus and Growth Potential Indicate a Promising 185% Upside

Alpha Tau Medical Ltd. (NASDAQ: DRTS), a Jerusalem-based biotechnology firm, is garnering significant attention with its groundbreaking work in oncology therapeutics. Specializing in diffusing alpha-emitters radiation therapy (Alpha DaRT), the..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a 67% Upside Potential in Medical Devices

Cytek Biosciences, Inc. (NASDAQ: CTKB), a pivotal player in the healthcare sector’s medical devices industry, offers a tantalizing 67.15% potential upside according to analyst ratings. With its roots firmly planted..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Potential 159% Upside in Biotech Sector

Entrada Therapeutics, Inc. (NASDAQ: TRDA) is making waves in the biotech sector with its innovative approach to treating neuromuscular diseases. With its market cap standing at $299.83 million, this clinical-stage..

Absci Corporation (ABSI) Stock Analysis: A Biotechnology Innovator with Over 200% Potential Upside

Absci Corporation (NASDAQ: ABSI), a pioneering entity in the biotechnology sector, is drawing considerable attention from investors, primarily due to its robust potential for upside. With a current market cap..

Anbio Biotechnology (NNNN) Stock Analysis: Navigating Revenue Challenges and Market Positioning

Anbio Biotechnology (NNNN), a promising player in the healthcare sector, specializes in medical instruments and supplies, with a focus on in vitro diagnostics (IVD) products. Based in Frankfurt, Germany, the..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Eye-Catching 59% Potential Upside for Biotech Investors

Investors with an appetite for risk-reward scenarios in the biotech sector might want to take a closer look at Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL). With a market capitalization of $378.72..

The Pennant Group, Inc. (PNTG) Investor Outlook: Exploring a 16.55% Potential Upside in Healthcare Services

The Pennant Group, Inc. (NASDAQ: PNTG) has emerged as a noteworthy player in the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of..

Evolent Health, Inc (EVH) Stock Analysis: A Potential 77.79% Upside with Strong Buy Ratings

Evolent Health, Inc. (NASDAQ: EVH) stands out in the healthcare sector, particularly within the health information services industry, as an intriguing investment opportunity. With a market capitalization of $995.55 million..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds